3.0.0 786 2023-01-11T13:28:33Z 2023-01-11T13:28:33Z House HR 2015-02-05 114 [Congressional Record Volume 161, Number 20 (Thursday, February 5, 2015)]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mrs. ELLMERS:H.R. 786.Congress has the power to enact this legislation pursuantto the following:The Commerce Clause: Article I, Section 8, Clause 3 of theU.S. Constitution gives Congress the power ``to regulatecommerce with foreign nations, and among the several states,and with the Indian tribes.''[Page H857]]]> hswm00 Ways and Means Committee House Standing hswm02 Health Subcommittee Referred to 2015-02-27T21:52:19Z Referred to 2015-02-05T14:08:15Z hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2015-02-06T18:54:16Z Referred to 2015-02-05T14:08:10Z 2015-02-27 hswm02 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2015-02-06 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2015-02-05 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2015-02-05 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100-A 9 Library of Congress 2015-02-05 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2015-02-05 Introduced in House IntroReferral Intro-H 9 Library of Congress 2015-02-05 Introduced in House IntroReferral 1000 9 Library of Congress E000291 Rep. Ellmers, Renee L. [R-NC-2] Renee Ellmers R NC L. 2 N B001251 Rep. Butterfield, G. K. [D-NC-1] G. K. Butterfield D NC 1 2015-02-05 True Health Administrative law and regulatory procedures Administrative remedies Advisory bodies Congressional oversight Department of Health and Human Services Drug safety, medical device, and laboratory regulation Government information and archives Government studies and investigations Health care costs and insurance Health care coverage and access Health information and medical records Immunology and vaccination Infectious and parasitic diseases Licensing and registrations Medicaid Medical research Medicare Public-private cooperation Trade restrictions User charges and fees Health 00 2015-02-05 Introduced in House 2015-06-11T20:07:05Z Vaccine Access, Certainty, and Innovation Act of 2015

This bill requires the Centers for Disease Control and Prevention (CDC) to report on the process used by the Advisory Committee on Immunization Practices (ACIP) in making recommendations on vaccines.

The Department of Health and Human Services (HHS) must issue final guidance to facilitate the use of expedited pathways for the development and licensure of vaccines to prevent certain infectious diseases.

The Public Health Service Act is amended to require the CDC to provide a vaccine developer, upon request, with information on public health needs and priorities and certain epidemiological analyses or data.

The Federal Food, Drug, and Cosmetic Act is amended to require the Food and Drug Administration to establish a process for designating diseases as tropical diseases included in the priority review voucher program. The amount of the priority review user fee is set to the cost difference between a priority review and a non-priority review.

The National Institutes of Health must support or conduct activities to advance the development of vaccines and must report on vaccine research.

Within 60 business days of a recommendation by ACIP, HHS must determine whether to update Medicare coverage of vaccines.

The Government Accountability Office must report on the impact of Medicare and Medicaid reimbursement rates on vaccine access.

For purposes of calculating a medical loss ratio, the cost of a program to increase adult immunization is accounted for: (1) by a private health insurer as an activity that improves health care quality, and (2) by a Medicare Advantage or Part D plan under title XVIII (Medicare) of the Social Security Act as a medical loss.]]> Vaccine Access, Certainty, and Innovation Act of 2015 Display Title Vaccine Access, Certainty, and Innovation Act of 2015 Official Title as Introduced To improve access, certainty, and innovation with respect to vaccines. Introduced in House IH Short Titles as Introduced Vaccine Access, Certainty, and Innovation Act of 2015 Introduced in House 2015-02-05T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-114hr786ih/xml/BILLS-114hr786ih.xml 2015-02-27 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.